Tsai Wen-Chen, Kung Pei-Tseng, Wang Shih-Ting, Huang Kuang-Hua, Liu Shih-An
Department of Health Services Administration, China Medical University, Taichung, Taiwan.
Department of Healthcare Administration, Asia University, Taichung, Taiwan.
Oral Oncol. 2015 Feb;51(2):105-11. doi: 10.1016/j.oraloncology.2014.11.006. Epub 2014 Dec 4.
The aim of this study was to investigate the association between multidisciplinary team (MDT) management and survival of oral cavity cancer patients using a nationwide database in Taiwan.
A nationwide cohort study was conducted between 2005 and 2008. The follow-up end point was 2010. Claims data of oral cavity cancer patients were retrieved from the Taiwan Cancer Registry Database. Secondary data were obtained from the Taiwan's National Health Insurance Research Database. Among 19,766 newly diagnosed oral cavity cancer patients, we identified 16,991 patients who underwent treatment between 2004 and 2008 for further analyses.
Overall survival was compared between patients who received MDT management (n=3324) and those who did not (n=13,367). Hazard ratios (HR) of death in patients with MDT management were also analyzed. Patients with MDT management had a lower risk of death when compared with that of patients without MDT management (HR: 0.94, 95% confidence intervals (CI): 0.89-1.00; P=0.032). The effect of MDT management on survival was stronger for male patients than for female patients (HR: 0.94, 95% CI: 0.89-1.00; P=0.040 versus HR: 0.98, 95% CI: 0.75-1.27; P=0.866). In addition, the effect of MDT management was strong among patients with a Charlson Comorbidity Index between 4 and 6, in those without coexisting catastrophic illness/injury, and in patients with stage IV diseases.
Survival rates in oral cavity cancer patients with MDT management appeared to be marginally better than those of patients without MDT management.
本研究旨在利用台湾的一个全国性数据库,调查多学科团队(MDT)管理与口腔癌患者生存率之间的关联。
2005年至2008年进行了一项全国性队列研究。随访终点为2010年。从台湾癌症登记数据库中检索口腔癌患者的索赔数据。二级数据来自台湾国民健康保险研究数据库。在19766例新诊断的口腔癌患者中,我们确定了16991例在2004年至2008年期间接受治疗的患者进行进一步分析。
比较了接受MDT管理的患者(n = 3324)和未接受MDT管理的患者(n = 13367)的总生存率。还分析了接受MDT管理的患者的死亡风险比(HR)。与未接受MDT管理的患者相比,接受MDT管理的患者死亡风险较低(HR:0.94,95%置信区间(CI):0.89 - 1.00;P = 0.032)。MDT管理对男性患者生存的影响比对女性患者更强(HR:0.94,95%CI:0.89 - 1.00;P = 0.040,而HR:0.98,95%CI:0.75 - 1.27;P = 0.866)。此外,MDT管理在Charlson合并症指数为4至6的患者、无并存灾难性疾病/损伤的患者以及IV期疾病患者中效果显著。
接受MDT管理的口腔癌患者的生存率似乎略高于未接受MDT管理的患者。